Biologic Name Standardization

Biologic Name Standardization is a methodological framework within regulatory bioinformatics that establishes consistent, unique, and globally recognized nomenclature for biologic products to ensure unambiguous identification, safety, and traceability across development, manufacturing, and clinical use.

2

Publications

2.1K

Citations

13

Authors

17

Institutions

Publications per year

2017–2026

0

Variants

Biologic Nomenclature Standardization

Authors

13

  1. RD
    R. Deans

    Athersys (United States), United States

    1 publications · 2K citations

    1

    h-index

  2. AK
    Armand Keating

    Princess Margaret Cancer Centre, Canada

    1 publications · 2K citations

    1

    h-index

  3. DG
    David G. Warnock

    University of Alabama at Birmingham, United States

    1 publications · 14 citations

    1

    h-index

  4. BS
    Bruce Strober

    Yale University, United States

    1 publications · 14 citations

    1

    h-index

  5. MD
    Massimo Dominici

    University of Modena and Reggio Emilia, Italy

    1 publications · 2K citations

    1

    h-index

1–5 of 13

Venues

  1. BioDrugs

    1 publications · 14 citations

    1

    h-index

  2. Cytotherapy

    1 publications · 2K citations

    1

    h-index

1–2